2.23 pm | 22 May 2013 |  Source: CNBC-TV18

Bino Pathiparampil of IIFL Capital told CNBC-TV18 that there has been a major rally in the sector over the last couple of years. Thus, many of the sto...

7.17 pm | 21 May 2013 |  Source: CNBC-TV18

Sharmila Joshi, Head of Equity, Peerless Securities is of the view that one can switch to Cipla from Ranbaxy Laboratories....

2.11 pm | 21 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com is of the view that one can sell Ranbaxy Laboratories....

9.13 am | 21 May 2013 |  Source: CNBC-TV18

Manas Jaiswal of manasjaiswal.com has recommended a buy rating on Adani Power and Dena Bank. ...

8.31 pm | 20 May 2013 |  Source: CNBC-TV18

Kunal Bothra, Sr Technical Analyst of LKP is of the view that, if Ranbaxy Laboratories breaks at Rs 440 level in the next couple of days the short-ter...

7.22 pm | 20 May 2013 |  Source: CNBC-TV18

SP Tulsian of sptulsian.com is of the view that one can short Adani Enterprises with a target of Rs 239."Short Ranbaxy Laboratories with a target of R...

11.51 am | 15 May 2013 |  Source: CNBC-TV18

Sudarshan Sukhani of s2analytics.com feels that a new uptrend seems to be starting in Ranbaxy Laboratories....

10.41 am | 15 May 2013 |  Source: CNBC-TV18

One should hold Ranbaxy Laboratories in the portfolio and from current level it can go to Rs 475, says Atul Badkar, VP - Institutional Equities - Deri...

10.38 am | 15 May 2013 |  Source: CNBC-TV18

For the index to touch 6100, Reliance Industries, Infosys and TCS will have to perform, says Vineet Bhatnagar opf Phillip Capital. He is bullish on p...

9.14 am | 15 May 2013 |  Source: CNBC-TV18

Rakesh Gandhi of FRR Shares is bullish on Ranbaxy Laboratories and recommended to buy around Rs 450 with a stop loss of Rs 430 and short-term target o...

3.54 pm | 14 May 2013 |  Source: CNBC-TV18

One can prefer Dr Reddys Laboratories, Sun Pharma over Ranbaxy, says Suresh Mahadevan, MD & Head of Indian Equities at UBS Securities....

10.47 am | 14 May 2013 |  Source: CNBC-TV18

Suresh Mahadevan, MD & Head of Indian Equities, UBS Securities is of the opinion that Nifty will end 2013, at higher end of 5600-6450 range and sees F...

10.26 am | 14 May 2013 |  Source: CNBC-TV18

Pharama analyst, Anmol Ganjoo beleives that acceptence of this felony charges will not only be sentiment negative for Ranbaxy but it will hit their b...

10.25 am | 10 May 2013 |  Source: CNBC-TV18

Hemant Thukral of Aditya Birla Money recommends investors to sell only if the Nifty goes below 6025 because he believes the momentum of the market is ...

1.12 pm | 09 May 2013 |  Source: CNBC-TV18

In an interview to CNBC-TV18, Manoj Garg, VP, Institutional Equities - Research, Edelweiss Securities shares his outlook on the pharmaceutical compani...